Fresenius Medical Care Corporation (FMS) Given Average Rating of “Hold” by Analysts

Shares of Fresenius Medical Care Corporation (NYSE:FMS) have earned a consensus recommendation of “Hold” from the nine brokerages that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and four have given a buy recommendation to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $44.00.

A number of analysts have recently issued reports on FMS shares. Zacks Investment Research upgraded Fresenius Medical Care Corporation from a “sell” rating to a “hold” rating and set a $53.00 price target for the company in a research report on Monday, October 9th. Royal Bank Of Canada reiterated a “neutral” rating on shares of Fresenius Medical Care Corporation in a research report on Tuesday, August 1st. BidaskClub downgraded Fresenius Medical Care Corporation from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Finally, DZ Bank AG reiterated a “buy” rating on shares of Fresenius Medical Care Corporation in a research report on Monday, August 7th.

ILLEGAL ACTIVITY WARNING: “Fresenius Medical Care Corporation (FMS) Given Average Rating of “Hold” by Analysts” was first posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The correct version of this news story can be viewed at https://sportsperspectives.com/2017/11/01/fresenius-medical-care-corporation-fms-given-average-rating-of-hold-by-analysts.html.

Several hedge funds and other institutional investors have recently made changes to their positions in FMS. Bank of New York Mellon Corp raised its holdings in shares of Fresenius Medical Care Corporation by 27.9% during the 1st quarter. Bank of New York Mellon Corp now owns 49,250 shares of the company’s stock valued at $2,075,000 after buying an additional 10,751 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Fresenius Medical Care Corporation by 2.7% during the 1st quarter. JPMorgan Chase & Co. now owns 95,267 shares of the company’s stock valued at $4,013,000 after buying an additional 2,537 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Fresenius Medical Care Corporation by 13.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 92,150 shares of the company’s stock valued at $3,882,000 after buying an additional 11,257 shares in the last quarter. UBS Group AG raised its holdings in shares of Fresenius Medical Care Corporation by 23.4% during the 1st quarter. UBS Group AG now owns 42,752 shares of the company’s stock valued at $1,801,000 after buying an additional 8,110 shares in the last quarter. Finally, Renaissance Technologies LLC purchased a new position in shares of Fresenius Medical Care Corporation during the 1st quarter valued at about $7,141,000. 2.61% of the stock is currently owned by institutional investors.

Fresenius Medical Care Corporation (NYSE:FMS) last issued its quarterly earnings results on Tuesday, August 1st. The company reported $0.48 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.53 by ($0.05). The business had revenue of $4.47 billion for the quarter, compared to the consensus estimate of $5.20 billion. Fresenius Medical Care Corporation had a net margin of 7.06% and a return on equity of 11.57%. The business’s revenue was up 11.1% compared to the same quarter last year. During the same quarter last year, the business posted $0.96 EPS.

About Fresenius Medical Care Corporation

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Analyst Recommendations for Fresenius Medical Care Corporation (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply